Abstract:OBJECTIVE:To construct the human cytomegalovirus (HCMV) pp65 DNA vaccine vector and VP22 and pp65 coexpressing vector. To evaluate and compare immunological effects in mice. METHODS:Twenty-one BALB/C mice were divided into 3 equal groups: pcDNA3.pp65 group undergoing injection of pcDNA3.pp65 as DNA vaccine, pVP22.pp65 group undergoing injection of pVP22.pp65, and control group undergoing injection of normal saline. HCMV pp65 expression vector pcDNA3.pp65, VP22 and pp65 coexpressing vector pVP22.pp65 were constructed by molecular biology methods. The vectors were immunized into BALB/C mice as DNA vaccines. The T cell proliferation activity and IL-2 biological activity were determined using MTT method. NK activity was detected using LDH release test. The serum IgM and IgG levels of HCMV, the concentrations of IL-2 and IL-4 in serum and supernatant of spleen cells were detected using ELISA method. RESULTS:The HCMV DNA vaccine expression vectors were successfully constructed. Some indexes of the two vaccine groups (pcDNA3.pp65 and pVP22.pp65), that is, T cell proliferation activity (5.11 and 5.55 for SI at 8th week respectively), NK activity (8.74% and 12.08% at 12th week respectively), IgM level (1.20 and 1.58 for A value at 6th week respectively) and IgG level (1.09 and 1.78 for A value at 6th week respectively) were higher than those of negative control, and pVP22.pp65 group was higher than pcDNA3.pp65 group (P < 0.05). The concentrations of IL-2 and IL-4 and the IL-2 biological activity were very low in sera of three groups which showed no significant difference between them (P > 0.05), but higher in the spleen supernatant and the pVP22.pp65 group was highest (411.11 pg/ml, 76.10 pg/ml for the concentrations of IL-2 and IL-4 and 0.22 for IL-2 biological activity). CONCLUSION:The HCMV pp65 could induce certain immunological activity, and VP22 could significantly enhance pp65 in vivo immunological activity.

Recombinant Expression of Antigen Epitope Genes of Human Cytomegalovirus and Immunogenicity Detection of the Fusion Protein

Development and characterization of HCMV recombinant subunit vaccines based on T-cell epitopes

Influence of FMDV epitopes-hsp70 fusion protein on immune responses in mice

Prokaryotic Expression and Immunogenicity of Recombinant Protein Fused with HSV-2 Gd and Gb CTL Epitopes

Cloning of Hemagglutinin Gene of Edmonston Vaccine Strain of Measles Virus and Fusion Protein Expression in Escherichia Coli

A Novel Polyclonal Antibody Against Human Cytomegalovirus: General Characteristics and Potential Application in Diagnosis

[VP22 Enhances the Immunological Activity of Human Cytomegalovirus Pp65 DNA Vaccine: Experimental Study with Mice].

Study on Expression of Human Cytomegalovirus PP65 Protein on the Surface of T7 Phages as Epitope

[Expression of DNA Fragment Encoding for Immunodominant Epitopes of 150kd Phosphoprotein of Human Cytomegalovirus in Escherichia Coli].

[Fusion Expression of O Type Foot-and-mouth Diseases Virus VP1 Gene and HSP70 Gene and Induction of Immune Responses in Mice].

Expression and Purification of Human Cytomegalovirus Tegument Protein Pp65 and Analysis of Its Immunologic Characteristics

Heterologous Expression of FMDV Immunodominant Epitopes and HSP70 in P. Pastoris and the Subsequent Immune Response in Mice

Towards a Novel Vaccine Against Human Cytomegalovirus Based on a Chimeric Ad5F35 Adenovirus Vector Expressing the Immunodominant Antigenic Domain 1 Epitope.

High-level expression of codon optimized foot-and-mouth disease virus complex epitopes and cholera toxin B subunit chimera in Hansenula polymorpha.

Human Cytomegalovirus Pp65 Protein Induces Specific Immune Response

Expression and Immunogenicity of the Eukaryotic Vector of Mimotope Mgc Derived from Glycoprotein C of Herpes Simplex Virus

Prokaryotic expression and immunogenicity of adenovirus antigenic epitope chimeric protein

CRM197-conjugated multi antigen dominant epitope for effective human cytomegalovirus vaccine development

Development of Two Potential Diagnostic Monoclonal Antibodies Against Human Cytomegalovirus Glycoprotein B

[The Immunization Effects of HBV Core Antigen and Surface Antigen Fusion Protein in Mice].

The Development of Chinese Specific Human Cytomegalovirus Polyepitope Recombinant Vaccine